BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23838260)

  • 1. Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.
    Wen W; Wu W; Romaine IM; Kaufmann K; Du Y; Sulikowski GA; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4562-6. PubMed ID: 23838260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.
    Wen W; Wu W; Weaver CD; Lindsley CW
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5102-6. PubMed ID: 25264075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.
    Ramos-Hunter SJ; Engers DW; Kaufmann K; Du Y; Lindsley CW; Weaver CD; Sulikowski GA
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5195-8. PubMed ID: 23916258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels.
    Kozek KA; Du Y; Sharma S; Prael FJ; Spitznagel BD; Kharade SV; Denton JS; Hopkins CR; Weaver CD
    ACS Chem Neurosci; 2019 Jan; 10(1):358-370. PubMed ID: 30136838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.
    Xu Y; Cantwell L; Molosh AI; Plant LD; Gazgalis D; Fitz SD; Dustrude ET; Yang Y; Kawano T; Garai S; Noujaim SF; Shekhar A; Logothetis DE; Thakur GA
    J Biol Chem; 2020 Mar; 295(11):3614-3634. PubMed ID: 31953327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel small-molecule selective activator of homomeric GIRK4 channels.
    Cui M; Xu K; Gada KD; Shalomov B; Ban M; Eptaminitaki GC; Kawano T; Plant LD; Dascal N; Logothetis DE
    J Biol Chem; 2022 Jun; 298(6):102009. PubMed ID: 35525275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3.
    Jelacic TM; Kennedy ME; Wickman K; Clapham DE
    J Biol Chem; 2000 Nov; 275(46):36211-6. PubMed ID: 10956667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent regulation of GIRK1 and GIRK2 subunits of the neuronal G protein gated K+ channel by GalphaiGDP and Gbetagamma.
    Rubinstein M; Peleg S; Berlin S; Brass D; Keren-Raifman T; Dessauer CW; Ivanina T; Dascal N
    J Physiol; 2009 Jul; 587(Pt 14):3473-91. PubMed ID: 19470775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
    Plummer HK; Dhar MS; Cekanova M; Schuller HM
    BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of Gβγ controls the basal activity of G-protein coupled inwardly rectifying potassium (GIRK) channels: crucial role of distal C terminus of GIRK1.
    Kahanovitch U; Tsemakhovich V; Berlin S; Rubinstein M; Styr B; Castel R; Peleg S; Tabak G; Dessauer CW; Ivanina T; Dascal N
    J Physiol; 2014 Dec; 592(24):5373-90. PubMed ID: 25384780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural elements in the Girk1 subunit that potentiate G protein-gated potassium channel activity.
    Wydeven N; Young D; Mirkovic K; Wickman K
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21492-7. PubMed ID: 23236146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.
    Wieting JM; Vadukoot AK; Sharma S; Abney KK; Bridges TM; Daniels JS; Morrison RD; Wickman K; Weaver CD; Hopkins CR
    ACS Chem Neurosci; 2017 Sep; 8(9):1873-1879. PubMed ID: 28697302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 2000 Apr; 129(8):1716-22. PubMed ID: 10780978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics.
    Weigl LG; Schreibmayer W
    Mol Pharmacol; 2001 Aug; 60(2):282-9. PubMed ID: 11455015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a G-Protein-Independent Activator of GIRK Channels.
    Zhao Y; Ung PM; Zahoránszky-Kőhalmi G; Zakharov AV; Martinez NJ; Simeonov A; Glaaser IW; Rai G; Schlessinger A; Marugan JJ; Slesinger PA
    Cell Rep; 2020 Jun; 31(11):107770. PubMed ID: 32553165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297.
    Huang Y; Zhang Y; Kong S; Zang K; Jiang S; Wan L; Chen L; Wang G; Jiang M; Wang X; Hu J; Wang Y
    Biomed Pharmacother; 2018 May; 101():362-370. PubMed ID: 29499411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G alpha(i) and G betagamma jointly regulate the conformations of a G betagamma effector, the neuronal G protein-activated K+ channel (GIRK).
    Berlin S; Keren-Raifman T; Castel R; Rubinstein M; Dessauer CW; Ivanina T; Dascal N
    J Biol Chem; 2010 Feb; 285(9):6179-85. PubMed ID: 20018875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
    Sharma S; Kozek KA; Abney KK; Kumar S; Gautam N; Alnouti Y; David Weaver C; Hopkins CR
    Bioorg Med Chem Lett; 2019 Mar; 29(6):791-796. PubMed ID: 30718161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral characterization of mice lacking GIRK/Kir3 channel subunits.
    Pravetoni M; Wickman K
    Genes Brain Behav; 2008 Jul; 7(5):523-31. PubMed ID: 18194467
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.